Shockwave Coronary Lithoplasty® Study (Disrupt CAD II)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT03328949
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT03328949
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Belgium, Denmark, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03328949. Allocation not applicable; no masking; primary purpose treatment. Start 2018-05-18 (actual); primary completion 2019-03-26 (actual). Results posted on 2019-11-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Shockwave Coronary Lithoplasty® Study (Disrupt CAD II)
- Condition
- Coronary Artery Disease
- Intervention (Device)
- IVL Coronary Lithotripsy System
- Lead sponsor
- Shockwave Medical, Inc.
Record details
- Record id
cardio:ct-nct03328949- Content hash
ac6d2c10f8e7fa8600a93ea4274bbf6a048a3dfed0adf8167d63203b518109eb